The unseen threat: anti-PL7 anti-synthetase mediated interstitial lung disease

作者
Maskeen K. Kullar,Prabhsimranjeet S. Randhawa,Jasmine Nirmal,Arashdeep Singh,Harpreet Thukral
出处
期刊:International Journal of Research in Medical Sciences [Medip Academy]
卷期号:13 (11): 4980-4983
标识
DOI:10.18203/2320-6012.ijrms20253634
摘要

Anti-synthetase syndrome (ASS) is a rare autoimmune disorder within the spectrum of idiopathic inflammatory myopathies, defined by the presence of anti-aminoacyl-tRNA synthetase antibodies, most commonly anti-Jo1. Less frequent antibodies, such as anti-PL7, are associated with predominant pulmonary involvement and minimal muscle symptoms. Interstitial lung disease (ILD) is the most serious complication and may be the initial or sole presenting feature. Due to its rarity and atypical manifestations, anti-PL7-associated ASS can be underdiagnosed, especially in elderly patients presenting with unexplained ILD. Herein this case reports the case of a 74-year-old woman who presented with exertional dyspnea and a persistent dry cough for three months. Examination revealed Raynaud’s phenomenon, hyperkeratotic skin changes on the hands (mechanic’s hands), and digital ulceration. Imaging confirmed bilateral ground-glass opacities consistent with ILD. Autoimmune serology showed a positive ANA (1:320, speckled pattern) and anti-PL7 antibody, with no evidence of myositis. Based on Connors et al's criteria, a diagnosis of anti-synthetase syndrome was made. The patient received high-dose intravenous corticosteroids and cyclophosphamide, with limited clinical improvement. She was discharged on request on long-term oxygen support and oral steroids for outpatient follow-up. This case highlights the diagnostic challenge of ASS, especially when classical myositis features are absent. Anti-PL7-positive patients often present with isolated ILD, carrying a poorer prognosis compared to anti-Jo1-positive patients, and may not respond to standard immunosuppression. Early recognition of dermatologic signs and prompt antibody testing are essential for diagnosis. Aggressive initial therapy may be required, and biologic agents should be considered for refractory cases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
JJyue发布了新的文献求助50
刚刚
wy完成签到,获得积分10
1秒前
arizaki7发布了新的文献求助10
2秒前
王一硕发布了新的文献求助10
2秒前
留蓝发布了新的文献求助10
3秒前
Owen的应助被夏梓硕采纳,获得10
3秒前
周林发布了新的文献求助10
4秒前
4秒前
wl完成签到,获得积分10
5秒前
humble发布了新的文献求助10
5秒前
羊羊羊完成签到,获得积分20
5秒前
白术完成签到,获得积分10
5秒前
7秒前
7秒前
jjj完成签到,获得积分10
8秒前
wanci的应助被Rauf采纳,获得10
8秒前
CHEN完成签到,获得积分10
9秒前
GIN的应助被胡萝卜卜采纳,获得10
9秒前
科研通AI6.4的应助被WYF1996采纳,获得10
10秒前
科研通AI65的应助被科研通管家采纳,获得10
10秒前
CipherSage的应助被科研通管家采纳,获得10
10秒前
大模型的应助被科研通管家采纳,获得10
10秒前
xlxl完成签到,获得积分10
10秒前
无极微光的应助被科研通管家采纳,获得20
10秒前
AAAA完成签到,获得积分10
10秒前
ding的应助被科研通管家采纳,获得10
10秒前
桐桐的应助被科研通管家采纳,获得10
10秒前
杜若完成签到,获得积分10
10秒前
酷波er的应助被科研通管家采纳,获得10
10秒前
11秒前
CipherSage的应助被科研通管家采纳,获得10
11秒前
JamesPei的应助被科研通管家采纳,获得10
11秒前
零负一的应助被科研通管家采纳,获得10
11秒前
自然的冥王星完成签到,获得积分10
11秒前
无极微光的应助被科研通管家采纳,获得20
11秒前
11秒前
11秒前
12秒前
深情安青的应助被科研通管家采纳,获得10
12秒前
搜集达人的应助被科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193348
求助须知:如何正确求助?哪些是违规求助? 9579548
关于积分的说明 21866040
捐赠科研通 7792906
什么是DOI,文献DOI怎么找? 3437242
关于科研通互助平台的介绍 2560702
邀请新用户注册赠送积分活动 2484066